A detailed history of Silvercrest Asset Management Group LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 11,992 shares of WST stock, worth $3.96 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,992
Previous 12,077 0.7%
Holding current value
$3.96 Million
Previous $3.98 Million 9.53%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$277.16 - $333.3 $23,558 - $28,330
-85 Reduced 0.7%
11,992 $3.6 Million
Q2 2024

Aug 14, 2024

SELL
$314.68 - $395.94 $3.8 Million - $4.78 Million
-12,077 Reduced 50.0%
12,077 $3.98 Million
Q2 2024

Aug 14, 2024

BUY
$314.68 - $395.94 $3.95 Million - $4.97 Million
12,551 Added 108.17%
24,154 $7.96 Million
Q1 2024

May 15, 2024

BUY
$338.27 - $413.0 $465,121 - $567,875
1,375 Added 13.44%
11,603 $4.59 Million
Q4 2023

Feb 14, 2024

BUY
$318.29 - $392.21 $305,558 - $376,521
960 Added 10.36%
10,228 $3.6 Million
Q3 2023

Nov 14, 2023

SELL
$354.9 - $412.41 $400,682 - $465,610
-1,129 Reduced 10.86%
9,268 $3.48 Million
Q2 2023

Aug 14, 2023

SELL
$334.63 - $382.47 $290,124 - $331,601
-867 Reduced 7.7%
10,397 $3.98 Million
Q1 2023

May 15, 2023

BUY
$232.5 - $346.47 $27,667 - $41,229
119 Added 1.07%
11,264 $3.9 Million
Q4 2022

Feb 14, 2023

BUY
$209.34 - $261.61 $82,270 - $102,812
393 Added 3.66%
11,145 $2.62 Million
Q3 2022

Nov 14, 2022

SELL
$246.08 - $343.65 $100,400 - $140,209
-408 Reduced 3.66%
10,752 $2.65 Million
Q2 2022

Aug 15, 2022

BUY
$280.61 - $420.45 $946,778 - $1.42 Million
3,374 Added 43.33%
11,160 $3.37 Million
Q1 2022

May 16, 2022

BUY
$357.49 - $445.92 $524,080 - $653,718
1,466 Added 23.2%
7,786 $3.2 Million
Q4 2021

Feb 14, 2022

SELL
$402.25 - $471.34 $547,462 - $641,493
-1,361 Reduced 17.72%
6,320 $2.96 Million
Q3 2021

Nov 15, 2021

BUY
$363.01 - $468.47 $38,116 - $49,189
105 Added 1.39%
7,681 $3.26 Million
Q2 2021

Aug 16, 2021

BUY
$284.77 - $363.2 $326,346 - $416,227
1,146 Added 17.82%
7,576 $2.72 Million
Q1 2021

May 17, 2021

BUY
$257.29 - $307.53 $55,317 - $66,118
215 Added 3.46%
6,430 $1.81 Million
Q3 2020

Nov 16, 2020

SELL
$224.99 - $288.02 $19,124 - $24,481
-85 Reduced 1.35%
6,215 $1.71 Million
Q2 2020

Aug 14, 2020

BUY
$149.8 - $227.17 $12,733 - $19,309
85 Added 1.37%
6,300 $1.43 Million
Q4 2019

Feb 14, 2020

SELL
$137.6 - $151.21 $127,968 - $140,625
-930 Reduced 13.02%
6,215 $934,000
Q1 2019

May 15, 2019

SELL
$94.53 - $110.2 $181,024 - $211,033
-1,915 Reduced 21.14%
7,145 $787,000
Q2 2018

Aug 14, 2018

BUY
$83.32 - $101.88 $7,498 - $9,169
90 Added 1.0%
9,060 $900,000
Q4 2017

Feb 14, 2018

SELL
$91.65 - $101.65 $1,649 - $1,829
-18 Reduced 0.2%
8,970 $885,000
Q3 2017

Nov 14, 2017

BUY
$84.54 - $96.75 $759,845 - $869,589
8,988
8,988 $865,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.5B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.